Page last updated: 2024-10-31

molsidomine and Brain Damage, Chronic

molsidomine has been researched along with Brain Damage, Chronic in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wen, TC1
Rogido, MR1
Moore, JE1
Genetta, T1
Peng, H1
Sola, A1

Other Studies

1 other study available for molsidomine and Brain Damage, Chronic

ArticleYear
Cardiotrophin-1 protects cortical neuronal cells against free radical-induced injuries in vitro.
    Neuroscience letters, 2005, Oct-14, Volume: 387, Issue:1

    Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Cerebral Infarctio

2005